Occurrence of myelodysplastic syndrome during paclitaxel- and carboplatin-based chemotherapy for recurrent ovarian cancer: Case report

Journals Menu

Follow SCIRP

ISSN Print: 2160-8792
ISSN Online: 2160-8806
www.scirp.org/journal/ojog
E-mail: ojog@scirp.org

Citations h5-index & Ranking

"Occurrence of myelodysplastic syndrome during paclitaxel- and carboplatin-based chemotherapy for recurrent ovarian cancer: Case report"
written by Hiroshi Takagi, Satoshi Ichigo, Kazutoshi Matsunami, Haruna Takagi, Tsuneko Ikeda, Takayuki Murase, Atsushi Imai,
published by Open Journal of Obstetrics and Gynecology, Vol.3 No.2, 2013

has been cited by the following article(s):

[1]	Factores de riesgo asociados a síndrome mielodisplásico: Una revisión sistemática exploratoria
	2021

[2]	Secondary Hodgkin Lymphoma and Myelodysplastic Syndrome (MDS) After Paclitaxel-Carboplatin Treatment in a Patient with Small Cell Lung Cancer
	PRILOZI, 2017

[3]	Secondary Hodgkin Lymphoma and Myelodysplastic Syndrome (MDS) After Paclitaxel-Carboplatin Treatment in a Patient with Small Cell Lung Cancer.
	2017

[4]	再発卵巣癌に対する化学療法中に骨髄異形成症候群を発症した 1 例
	2016

[5]	Appearance of Acute Myelogenous Leukemia (AML) in a Patient with Breast Cancer after Adjuvant Chemotherapy: Case Report and Review of the Literature
	Iranian Journal of Cancer Prevention, 2015

[6]	Therapy Related Myelodysplasia/Myeloproliferative Neoplasia-Unclassified with Acute Leukemic Transformation Following Paclitaxel and Carboplatin Based Chemotherapy in an Ovarian Cancer Patient
	Indian Journal of Hematology and Blood Transfusion, 2014

[7]	Therapy related myelodysplasia/myeloproliferative neoplasia-unclassified with acute leukemic transformation following Paclitaxel and Carboplatin based …
	Indian Journal of Hematology and Blood Transfusion, 2014

[1]	Secondary Hodgkin Lymphoma and Myelodysplastic Syndrome (MDS) After Paclitaxel-Carboplatin Treatment in a Patient with Small Cell Lung Cancer PRILOZI, 2017 DOI:10.2478/prilozi-2018-0010

[2]	Secondary Hodgkin Lymphoma and Myelodysplastic Syndrome (MDS) After Paclitaxel-Carboplatin Treatment in a Patient with Small Cell Lung Cancer PRILOZI, 2017 DOI:10.2478/prilozi-2018-0010

[3]	Secondary Hodgkin Lymphoma and Myelodysplastic Syndrome (MDS) After Paclitaxel-Carboplatin Treatment in a Patient with Small Cell Lung Cancer PRILOZI, 2017 DOI:10.2478/prilozi-2018-0010

Follow SCIRP